BioExx Specialty Proteins Ltd. Produces World’s First Commercial Canola Protein Isolate to 95% Purity

TORONTO, ONTARIO--(Marketwire - August 09, 2010) - BioExx Specialty Proteins Ltd. (TSX: BXI) is pleased to announce that it has successfully produced the world’s first commercial-scale canola protein isolate, known as Isolexx™. The product was produced in the second full-scale protein run at the Saskatoon facility and was repeatedly tested in both the BioExx lab and at the independent testing facilities of POS Pilot Plant Corp. Average indicated purity at BioExx was 95.8% and the average at POS was 94.8%, with all other characteristics being similar to or better than the product from the recent initial protein run.

The plant was also able to much more thoroughly recover the product that was produced, resulting in an exceptionally strong yield of protein isolate at over 90% of what has been forecast for long-term continuous operations. This was achieved by ensuring the batch run was operated as close to a continuous process as possible, thus avoiding the precipitate issues experienced in the first run and by controlling the operating parameters of the large spray dryer in an improved manner.

Being the first company to produce and deliver canola protein isolates to the multi-billion dollar global protein market creates a tremendous opportunity for BioExx. Isolexx™ compares very favourably against other plant-based proteins, such as soy and pea protein isolates, as well as higher priced animal-based protein isolates, such as whey and caseinates. Potential customers who have tested Isolexx™ have been impressed by its high nutritional value, low allergenicity, benign flavour, and excellent solubility and functionality. In addition, recent trials have indicated that Isolexx™ has very good digestibility and is well suited, as an example, for use in nutritional and protein bars, with lower water absorption than traditional isolates (leading to extended shelf life and low bar hardening), and being functionally superior to soy and comparable to whey proteins.

The production run consisted of 1.3 metric tonnes of meal that had been processed in the BioExx pilot plant and utilized all of the full scale equipment necessary to recover protein from the meal. The company has used this approach to minimize the operating variables while starting up the protein facility. It should be noted that it remains the intention of the Company to produce Isolexx™ at an industry-standard commercial purity closer to 90%. Now that the desired protein results have been proven, the Company will continue with its start-up and ramp-up of the remainder of the Saskatoon plant.

“Today is a day for which everyone involved with this company has waited. The level of commitment and effort we have received from the plant team, and our consultants and contractors, in the past few months has been extraordinary. To be able to prove the ability to operate the plant so successfully and so quickly after our first run is a testament to the quality of work contributed by the entire team,” said BioExx CEO, Chris Carl. “This has not been an easy road and we still have a great deal of work ahead of us to bring the plant to full continuous operation, and to complete the plant certifications and ancillary systems required for human food status, but these near-term milestones seem much more easily attainable now that we have so clearly proven the commercial viability of our protein purification process.”

About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.

To find out more about BioExx Specialty Proteins Ltd. (TSX: BXI), please visit www.bioexx.com

The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management’s current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, competition in its target markets, the demand for BioExx’s products, the availability of funding, the efficacy of its technology, and the anticipated costs of BioExx’s plant construction and operation. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx’s expectations and projections.